Tika R Malla

5PUBLICATIONS
40CO-AUTHORS
Proteins and peptidesBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 22, 2023
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease.

Takashi Miura, Tika R Malla, C David Owen

|Feb 09, 2023
Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine.

Lennart Brewitz, Leo Dumjahn, Yilin Zhao

|Dec 01, 2021
Structure-Activity Studies Reveal Scope for Optimisation of Ebselen-Type Inhibition of SARS-CoV-2 Main Protease.

Siegfried T D Thun-Hohenstein, Timothy F Suits, Tika R Malla

|Nov 11, 2021
Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding.

H T Henry Chan, Marc A Moesser, Rebecca K Walters

|Jan 19, 2021
Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 Mpro inhibitors.

Tika R Malla, Anthony Tumber, Tobias John

Pageof 1

Frequent Collaborators

5 joint publications

Christopher J Schofield

4 joint publications

Lennart Brewitz

4 joint publications

Martin A Walsh

3 joint publications

C David Owen